India Must Focus On Stopping Drug-Resistant TB Transmission, Involve All Sectors In Ending TB

Huffington Post India: Understanding India’s Evolving Tuberculosis Challenge
Nerges Mistry, trustee and joint director of the Foundation for Medical Research

“…Given its dangerous implications, curbing transmission-generated drug-resistant TB in India is the need of the hour. This is only possible if every suspected patient undergoes drug susceptibility testing during their initial TB diagnosis to guide an appropriate, timely, and effective treatment regime suited to their individual needs. This will rapidly reduce transmission of severe disease and prevent needless deaths. … Ending tuberculosis in India in its most comprehensive form will require the involvement of non-medical sectors such as nutrition, education, sanitation, engineering, urban planning, and judicial. This is a historical lesson that India can ignore only at its peril” (1/16).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.